ICON Bioscience is an early stage biopharma company that is pioneering dramatic changes in the delivery of ophthalmic pharmaceuticals. Their Verisome platform allows for delivery of slow release anti-inflammatories in post-cataract surgery patients. This is amazing technology for a large and growing market.
There was some history with the existing company identity. I was asked to bring something new to the table, but keep the history behind the identity mark.
From there, I developed branding and a search engine friendly site which explained the technology and robust product pipeline.
To visually explain the technology to investors and partners, I was tasked to create an animation. By collaborating with ICON scientists and a small animation team in Liverpool, I was able to develop this animation within 2 weeks.